Gene · 10313
NIH grants668
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 668
Download this page as JSON| Grant | Title | RTN3 papers | Newest fiscal year |
|---|---|---|---|
| R01AA020744 | MicroRNAs in Alcoholic Liver Disease | 1 | 2023 |
| R01AI143254 | Subtractive assembly approaches for inferring disease-associated microbial genes and pathways from microbiome sequencing data | 1 | 2023 |
| R01CA089151 | Pathogenesis of Cancer - Role of EGF Receptor Endocytosis | 1 | 2023 |
| R01DA010711 | Membrane Trafficking of Opioid and Adrenergic Receptors | 1 | 2023 |
| R01DK117639 | Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration | 1 | 2023 |
| R01EB029523 | High-resolution volumetric imaging of metabolic activity in tissues and its application to tumor metabolism | 1 | 2023 |
| R01ES030950 | Environmental bisphenol exposure, infant brain and behavior: Human and animal models | 1 | 2023 |
| R01GM087544 | Studies on Protein Lipidation | 1 | 2023 |
| R01HL151438 | Discovery of modifier genes in cardiomyopathy | 1 | 2023 |
| R01LM011834 | Intention-aware Recommender System for Improving Trauma Resuscitation Outcomes | 1 | 2023 |
| R01MH120212 | GPR88 localization to primary cilia and its impact on striatal cAMP signaling | 1 | 2023 |
| R01NS077111 | Modulating selective autophagy to modify Huntington's disease | 1 | 2023 |
| R01NS085054 | Identifying symptomatic and neuroprotective strategies for cereballar ataxia | 1 | 2023 |
| R03DE030562 | Synergistic degradation of the bonded interface: A new approach to evaluate the bond strength of dental restoration | 1 | 2023 |
| R21NS123814 | Cholinergic neuron degeneration after HI: New target for delayed therapy of neonatal HI to improve Learning and Memory Deficits | 1 | 2023 |
| R35GM130292 | Regulation of mitochondrial dynamics by ERAD | 1 | 2023 |
| T32CA080416 | Interdisciplinary Training in Cancer Research | 1 | 2023 |
| T32GM007377 | Training Program in Molecular and Cellular Biology | 1 | 2023 |
| U01AA026933 | Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement | 1 | 2023 |
| U19AI089681 | Amazonian Center of Excellence in Malaria Research | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/grants?page=9